02.03.2023 • NewsArchromaHuntsmanSK Capital Partners

Archroma Integrates Acquired Huntsman Assets

With the completion of its acquisition of Huntsman Textile Effects on Feb. 28, Swiss specialty chemicals producer Archroma, a portfolio company of US private investment firm SK Capital Partners, has revamped its operational structure.

The former Huntsman businesses have been integrated with Archroma’s existing Brand Performance Textile Specialties activities into a new unit called Archroma Textile Effects and headed by Rohit Aggarwal, former president of Huntsman Textile Effects, as divisional president and CEO. Aggarwal will also function as president Asia.

Archroma’s Packaging & Paper Specialties and Coatings, Adhesives & Sealants businesses have been combined with the Huntsman assets into a division called Archroma Paper, Packaging & Coatings. The business will be led by Sameer Singla as president and CEO. Singla will also be president Americas and Europe, Middle East & Africa.

Archroma Core team: (from left) Thomas Bucher, Heike van de Kerkhof, Rohit...
Archroma Core team: (from left) Thomas Bucher, Heike van de Kerkhof, Rohit Aggarwal, Sammer Singla © Archroma

With the acquired Huntsman units, Archroma will have more than 5,000 employees in 42 countries, along with 35 production sites. Group CEO Heike van de Kerkhof said the combined product portfolios will be “highly complementary.”

The CEO said the new structure will ensure that both divisions obtain the resources and focus needed. In particular, she said Archroma is committed to supporting global megatrends and societal shifts such as circular fashion, plastic-to-paper replacement and water-based paints and coatings.

Author: Dede Williams, Freelance Journalist

Company

Logo:

Archroma


Pratteln
Switzerland

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.